Advertisement

Theophylline

  • Elliot E. Ellis
Part of the Current Clinical Practice book series (CCP)

Abstract

Theophylline was introduced into clinical medicine almost 50 years ago for the treatment of asthma. The drug was widely used for 20 years after its introduction; however, following reports of adverse reactions, including death, there was a pronounced decline of theophylline prescribing, particularly for children. In the mid-1960s and the early 1970s when the pharmacokinetics of the drug began to be elucidated, an increase in the use of theophylline occurred, and it became the most commonly prescribed drug for the treatment of asthma. This trend is now being reversed; doubts are being raised even about its bronchodilator activity in certain clinical settings, e.g., acute asthma. Furthermore, concurrent with its increased use, theophylline toxicity, which was well characterized in the 1950s and 1960s, was rediscovered, dampening enthusiasm for the drug.

Keywords

Acute Asthma Status Asthmaticus Serum Theophylline Theophylline Clearance Serum Theophylline Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Ellis EE Theophylline toxicity. J Allergy Clin Immunol 1985; 76: 297 - 301.PubMedCrossRefGoogle Scholar
  2. Ellis EF, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics 1976; 58: 542 - 547.PubMedGoogle Scholar
  3. Hendeles L, Weinberger M. Theophylline: a “state of the art” review. Pharmacotherapy 1983; 3: 2-44..PubMedGoogle Scholar
  4. Hendeles L, Weinberger M, Szefler S, et al. Safety and efficacy of theophylline in children with asthma. J Pediatr 1992; 120: 177 - 183.PubMedCrossRefGoogle Scholar
  5. Howell RE. Multiple mechanisms of xanthine action on airway reactivity. J Pharmacol Exp Ther 1990; 225: 1008 - 1013.Google Scholar
  6. Kidney J, Dominguez M, Taylor P, et al. Immunomodulation by theophylline in asthma. Am J Respir Crit Care Med 1995; 151: 1907 - 1914.PubMedGoogle Scholar
  7. Littenberg B. Aminophylline treatment in severe, acute asthma. JAMA 1988; 259: 1678 - 1684.PubMedCrossRefGoogle Scholar
  8. May CD. History of the introduction of theophylline into the treatment of asthma. Clin Allergy 1974; 4: 211 - 217.PubMedCrossRefGoogle Scholar
  9. Mitenko PA, Ogilvie RI. Rational intravenous does of theophylline. N Engl J Med. 1973; 289: 600 - 603.PubMedCrossRefGoogle Scholar
  10. Ward AJM, McKenniff MG, Evans JM, et al. Theophylline—an immunomodularity role in asthma? Am Rev Respir Dis 1993; 147: 518 - 523.PubMedGoogle Scholar
  11. Weinberger M, Hendeles L. Theophylline. In: Middleton E Jr, Reed CE, Ellis EF, et al, eds. Allergy: Principles and Practice. St. Louis: Mosby, 1993.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Elliot E. Ellis

There are no affiliations available

Personalised recommendations